title: Angiokeratoma corporis diffusum in a patient with Hodgkin lymphoma: a new paraneoplastic skin manifestation?
authors.forename: F
authors.initials: F
authors.lastname: Han
authors.forename: P
authors.initials: P
authors.lastname: Wang
authors.forename: Z
authors.initials: Z
authors.lastname: Li
authors.forename: J H
authors.initials: JH
authors.lastname: Zheng
authors.forename: Q
authors.initials: Q
authors.lastname: Wang
authors.forename: A E
authors.initials: AE
authors.lastname: Xu
authors.forename: Z M
authors.initials: ZM
authors.lastname: Wang
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000627:therapeutic use; D003606:Dacarbazine / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D000795:Fabry Disease / Q000209:etiology* / Q000473:pathology; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008297:Male; D010257:Paraneoplastic Syndromes / Q000209:etiology* / Q000473:pathology; D012878:Skin Neoplasms / Q000150:complications* / Q000188:drug therapy; D014747:Vinblastine / Q000627:therapeutic use
chemical_list: D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin